Ophthalmology Proc denials in California external review

In the California DMHC record, independent physician reviewers decided 65 published external-review cases involving ophthalmology proc and overturned the plan’s denial in 41.5%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
65
2002–2019
Overturned
41.5%
27 denials reversed

By denial reason

The stated reason changes which facts, criteria, and records matter.
Denial reasonDecisionsOverturned
medical necessity39
33.3%
experimental / investigational23
56.5%

Within this category

Subcategories with at least 15 published decisions.
SubcategoryDecisionsOverturned
Other43
46.5%
Cataract Surgery17
35.3%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
39
33.3%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
23
56.5%
Urgent Care
Expedited reviews, decided in days rather than weeks.
3
33.3%
Typical time to a decision
21 days
Most land between 12 and 24 days
Handled as urgent
7.7%
Expedited when a delay would cause harm
Recent direction
Rising
45%70% overturned, last three years

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization coverage for eyelid surgery (CPT 67908 – repair blepharoplasty conjunctive-tarso-muller’s muscle-levator resection (1 unit) and CPT 15823 – blepharoplasty upper eyelid with excessive skin (1 unit)) for treatment of the enrollee’s bilateral dermatochalasis and myogenic ptosis. Findings: The physician reviewer found that upper eyelid ptosis can lead to functional impairment requiring surgical repair.
Medical Necessity · 2017 · IMR MN17-26331
An enrollee has requested reimbursement for vision therapy. Current concepts in convergence insufficiency describe this as a condition in which an individual has difficulty with reading “at near” because of their inability to bring their eyes close together. Colleagues have noted that convergence insufficiency can develop following head trauma. While the standard treatment for patients with convergence insufficiency would be to start with home-based exercises including pencil push-ups, studies such as the Comparison of Three Vision Therapy Approaches by colleagues have shown that it is not unreasonable to start office-based vision therapy, which has also been shown to be effective. In this case, the patient’s initial examination clearly documented objective evidence of convergence insufficiency. The patient’s near point of convergence was at and exophoria was also noted.
Medical Necessity · 2019 · IMR MN19-30087

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Physician 1: The patient is a 58-year-old female with an asymptomatic pterygium in the left eye. She was referred to an ocular surgeon for evaluation and excision of the lesion. The specialist recommended reconstruction of the ocular surface with an amniotic graft after excision, and a request for authorization was submitted to the Health Plan. The Health Plan considers this an investigational procedure and authorization was denied.There is no peer-reviewed evidence that pterygium excision with amniotic membrane transplantation is superior to any currently recognized surgical modalities. Although amniotic membrane graft is a recognized and accepted procedure, it has not yet become the standard of care. In a fairly routine situation such as this one, a more established surgical technique offers the best outcome for the patient.
Experimental/Investigational · 2006 · IMR EI06-5892
Physician 1: The patient is a 66-year-old female who has a history of melanoma of the right eye. She also had degenerative eyesight. In August 2004, a Heidelberg retinal test was performed to rule out glaucoma. The Health Plan has denied reimbursement for the Heidelberg test on the basis it is considered experimental.There is some issue as to the clinician’s diagnosis of suspected glaucoma in this patient. The examinations from July and August of 2004 show some discrepancies in the appearance of the optic nerve, and it is questionable if the intraocular pressure was significantly elevated. Though there were asymmetric cup to disc ratios noted on the 8/2/04 exam, the optic nerves were shown to be equal on the 7/20/04 exam.
Experimental/Investigational · 2005 · IMR EI05-4308

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this category of care generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving ophthalmology proc, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied for ophthalmology proc? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39